Genistein combined with FOLFOX or FOLFOX –Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
ConclusionWe observed that adding Genistein to FOLFOX or FOLFOX –Bevacizumab was safe and tolerable. Efficacy results are notable and warrant verification in larger clinical trials.Clinical trial registrationThe study was registered at ClinicalTrials.gov Identifier: NCT01985763.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Drugs & Pharmacology | Headache | Hypertension | Soy isoflavones | Study